Overview

IGF-1 LR3 is a modified analogue of insulin-like growth factor-1 (IGF-1) studied for its interaction with IGF-1 receptor signaling and related growth-factor pathways.

Current research examines IGF-1 receptor activity, cellular growth and differentiation pathways, metabolic signaling, peptide-protein interactions, and associated pharmacological mechanisms.

Research Focus

• IGF-1 receptor signaling

• Growth-factor pathway research

• Cellular growth and differentiation mechanisms

• Metabolic signaling pathways

• Peptide and protein pharmacology research
  
  

Product Specifications

Form: Lyophilized peptide

In-Stock Strengths: 1 mg

Special-Order Strengths: 0.1 mg

Special Orders

Additional strengths may be available by special order. Availability, pricing, and lead times are subject to confirmation.

Storage

Store refrigerated at 2–8°C, unless otherwise specified.

Research Use Only

For laboratory and research applications only. Not intended for human or veterinary use, consumption, diagnosis, treatment, or clinical application.